Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 88.89 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $23.252 million which beat the analyst consensus estimate of $20.800 million by 11.79 percent. This is a 1.63K percent increase over sales of $1.341 million the same period last year.